Allergan Sues Again To Block Generic Latisse
Allergan Inc. filed a patent infringement suit against Hi-Tech Pharmacal Co. Inc. in North Carolina on Wednesday in its latest effort to block a generic version of the eyelash growth treatment...To view the full article, register now.
Already a subscriber? Click here to view full article